The Effect of Hypnotherapy Methods On The Quality Of Life Of Menopausal Women Through The Assessment Of The Menopause Specific Quality Of Life (Menqol) Modification Scale And Serotonin Biomarkers

Objective: This study was conducted to measure the potential of hypnotherapy in improving the quality of life of menopausal women, through an assessment study of the Menopause Specific Quality of Life (MenQoL) and Serotonin modification scale. Materials and Methods: The study uses a quasi-experimental design with a pretest-posttest group control approach. Data collection in Malang with menopausal female respondents (45-60 years old), treatment group 75 and control 75. Implantation is carried out 2 times with an interval of 4 mg. It will be carried out from March 2023 to May 2023. Results: Results of the assessment of the MenQoL modified scale questionnaire (44 items) with 30 respondents: The validity test of the questionnaire with an r value between 0.958-0.998 (meaning: Valid) and the reliability test (Cronbach's Alpha) r = 1.00 (meaning: Very High). Results of the Hypnotherapy Effect test on MenQoL (wilcoxon): p-value 0.000 (significantly different) in the experimental group and p-value 0.357 (no significant difference) in the control group. Results of the Hypnotherapy Effect test on Serotonin Biomarkers (wilcoxon test): p-value 0.000 (significantly different) in the experimental group and p-value 0.219 (no significant difference) in the control group. The results of the difference (∆) between the pre and post averages: MenQoL experiment -31.58 < MenQoL control 3.95 and Serotonin experiment -2,733.48 < Serotonin control 51,241.92. Results of the normalized gain test (strength) of MenQoL with decreasing value (improvement): 86.6% of the experimental group and MenQoL with increased value (deterioration): 57.3%. Serotonin with increased values (improvement): 100 % of the experimental group and Serotonin with decreased values (improvement): 52 %. Conclusion: Hypnotherapy provides improvement in the quality of life of menopausal women through improvement of MenQoL and improvement of Serotonin biomarkers.